Macrolide Antibiotics Global Market Report 2024

Description

Macrolide antibiotics are characterized by a macrocyclic lactone ring to which one or more sugars are attached. They exert their antibacterial effect by binding to the 50S ribosomal subunit, thereby inhibiting bacterial protein synthesis. This mechanism makes them effective against a wide range of Gram-positive bacteria and some Gram-negative bacteria.

Azithromycin, clarithromycin, erythromycin, fidaxomicin, and telithromycin are the main types of macrolide antibiotics. Azithromycin, for instance, inhibits bacterial growth by disrupting protein synthesis. It is used to treat respiratory tract infections, skin infections, sexually transmitted infections, gastrointestinal infections, among others. Azithromycin can be administered orally, parenterally, or through other routes. It is distributed through hospital pharmacies, retail drug stores, and online providers, and is utilized by various end users such as hospitals, dermatology clinics, outpatient clinics, ambulatory centers, and research laboratories.

The macrolide antibiotics market research report is one of a series of new reports from The Business Research Company that provides macrolide antibiotics market statistics, including macrolide antibiotics industry global market size, regional shares, competitors with a macrolide antibiotics market share, detailed macrolide antibiotics market segments, market trends and opportunities, and any further data you may need to thrive in the macrolide antibiotics industry. This macrolide antibiotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The macrolide antibiotics market size has grown rapidly in recent years. It will grow from $52.98 billion in 2023 to $59.07 billion in 2024 at a compound annual growth rate (CAGR) of 11.5%. The growth observed in the historical period can be credited to factors such as increasing antibiotic resistance, approvals for new formulations, a rise in infectious diseases, and initiatives from governments and healthcare sectors.

The macrolide antibiotics market size is expected to see rapid growth in the next few years. It will grow to $91.64 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%. The forecast period growth is anticipated due to an increase in respiratory infections driven by factors such as a rise in combination therapies, a growing global geriatric population, heightened awareness and diagnostics, and the expansion of telemedicine and online pharmacy services. Key trends expected in the forecast period include advancements in drug delivery systems and formulations, the development of novel macrolide antibiotics, progress in telemedicine and remote healthcare services, and the adoption of eco-friendly manufacturing processes for macrolide antibiotics.

The growth of the macrolide antibiotics market is expected to be driven by the increasing prevalence of skin infections in the coming years. Skin infections occur when harmful microorganisms invade the skin, causing inflammation and often accompanied by symptoms such as redness, swelling, and pain. Factors contributing to the rise in skin infections include poor hygiene practices, compromised immune systems, exposure to environmental pollutants, antibiotic resistance, and inadequate wound care. Macrolide antibiotics are commonly prescribed to treat skin infections caused by bacteria such as Staphylococcus aureus or Streptococcus pyogenes, especially in cases of penicillin allergy or resistance. For example, according to the UK Health Security Agency (UKHSA) in September 2022, the percentage of Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia cases attributed to skin and soft tissue infections increased from 25.7% to 33.7% between April 2020 to March 2021 and April 2021 to March 2022. Similarly, for Methicillin-Sensitive Staphylococcus aureus (MSSA) bacteremia cases, the percentage rose from 27.2% to 28.5% over the same period, indicating a rising trend in skin infections driving the macrolide antibiotics market.

Key players in the macrolide antibiotic market are focusing on developing generic formulations to enhance accessibility, reduce treatment costs, and broaden their market presence. Generic formulations are unbranded versions of these drugs containing the same active ingredients, dosage, and strength as the original branded medications. For instance, Teva Pharmaceutical Industries Ltd., an Israel-based pharmaceutical company, launched its generic version of Erythromycin Tablets USP in May 2021 in the United States. This generic medication is used to treat or prevent various bacterial infections, including respiratory tract infections, skin infections, and infections of the ear, nose, and throat. Erythromycin, a macrolide antibiotic, works by inhibiting bacterial growth, thus alleviating symptoms and preventing infection spread. The generic Erythromycin Tablets USP is available in strengths such as 250 mg and 500 mg, offering patients a more affordable treatment option for bacterial infections.

In April 2024, Aztiq, an Iceland-based long-term investment fund, acquired Alvogen Emerging Markets Holdings Limited from PTT Public Company Limited for an undisclosed sum. The acquisition aims to accelerate Adalvo's growth and expansion by leveraging the combined strengths of Aztiq and Innobic (Asia), PTT's wholly-owned Life Science arm. Adalvo, a US-based pharmaceutical company, specializes in providing macrolide antibiotics.

Major companies operating in the macrolide antibiotics market are Pfizer Inc., Roche Holding AG, Merck Sharp & Dohme Corp, AbbVie Inc., Bayer AG, Sanofi S.A, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc., Eli Lily and Company, Amgen Inc., Teva Pharmaceutical Industries Limited, Mylan N.V., Daiichi Sankyo, Sun Pharmaceutical Industries Limited, Cipla Limited, Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd., Zhejiang Guobang Pharmaceutical Co. Ltd., Fresenius Kabi USA, WOCKHARDT, Crescent Pharma Limited, Wellona Pharma Private Limited

North America was the largest region in the macrolide antibiotics market in 2023. The regions covered in the macrolide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the macrolide antibiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The macrolide antibiotics market consists of sales of oral tablets and capsules such as dirithromycin, josamycin, spiramycin, and roxithromycin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Macrolide Antibiotics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on macrolide antibiotics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for macrolide antibiotics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The macrolide antibiotics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drugs: Azithromycin; Clarithromycin; Erythromycin; Fidaxomicin; Telithromycin
2) By Indication: Respiratory Tract Infections; Skin Infections; Sexually Transmitted Infections; Gastrointestinal Infections; Other Indications
3) By Route Of Administration: Oral; Parenteral; Other Route Of Administrations
4) By Distribution Channel: Hospital Pharmacies; Drug Stores And Retail Pharmacies; Online Providers
5) By End User: Hospital; Dermatology Clinic; Clinic; Ambulatory Centre; Research Laboratories
Companies Mentioned: Pfizer Inc.; Roche Holding AG; Merck Sharp & Dohme Corp; AbbVie Inc.; Bayer AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18915

1. Executive Summary

2. Macrolide Antibiotics Market Characteristics

3. Macrolide Antibiotics Market Trends And Strategies

4. Macrolide Antibiotics Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Macrolide Antibiotics Market Size and Growth

5.1. Global Macrolide Antibiotics Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Macrolide Antibiotics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Macrolide Antibiotics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Macrolide Antibiotics Market Segmentation

6.1. Global Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Azithromycin
Clarithromycin
Erythromycin
Fidaxomicin
Telithromycin
6.2. Global Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Respiratory Tract Infections
Skin Infections
Sexually Transmitted Infections
Gastrointestinal Infections
Other Indications
6.3. Global Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral
Parenteral
Other Route Of Administration
6.4. Global Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Drug Stores And Retail Pharmacies
Online Providers
6.5. Global Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital
Dermatology Clinic
Clinic
Ambulatory Centre
Research Laboratories

7. Macrolide Antibiotics Market Regional And Country Analysis

7.1. Global Macrolide Antibiotics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Macrolide Antibiotics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Macrolide Antibiotics Market

8.1. Asia-Pacific Macrolide Antibiotics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Macrolide Antibiotics Market

9.1. China Macrolide Antibiotics Market Overview
9.2. China Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Macrolide Antibiotics Market

10.1. India Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Macrolide Antibiotics Market

11.1. Japan Macrolide Antibiotics Market Overview
11.2. Japan Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Macrolide Antibiotics Market

12.1. Australia Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Macrolide Antibiotics Market

13.1. Indonesia Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Macrolide Antibiotics Market

14.1. South Korea Macrolide Antibiotics Market Overview
14.2. South Korea Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Macrolide Antibiotics Market

15.1. Western Europe Macrolide Antibiotics Market Overview
15.2. Western Europe Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Macrolide Antibiotics Market

16.1. UK Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Macrolide Antibiotics Market

17.1. Germany Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Macrolide Antibiotics Market

18.1. France Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Macrolide Antibiotics Market

19.1. Italy Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Macrolide Antibiotics Market

20.1. Spain Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Macrolide Antibiotics Market

21.1. Eastern Europe Macrolide Antibiotics Market Overview
21.2. Eastern Europe Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Macrolide Antibiotics Market

22.1. Russia Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Macrolide Antibiotics Market

23.1. North America Macrolide Antibiotics Market Overview
23.2. North America Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Macrolide Antibiotics Market

24.1. USA Macrolide Antibiotics Market Overview
24.2. USA Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Macrolide Antibiotics Market

25.1. Canada Macrolide Antibiotics Market Overview
25.2. Canada Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Macrolide Antibiotics Market

26.1. South America Macrolide Antibiotics Market Overview
26.2. South America Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Macrolide Antibiotics Market

27.1. Brazil Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Macrolide Antibiotics Market

28.1. Middle East Macrolide Antibiotics Market Overview
28.2. Middle East Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Macrolide Antibiotics Market

29.1. Africa Macrolide Antibiotics Market Overview
29.2. Africa Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Macrolide Antibiotics Market Competitive Landscape And Company Profiles

30.1. Macrolide Antibiotics Market Competitive Landscape
30.2. Macrolide Antibiotics Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Roche Holding AG
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Merck Sharp & Dohme Corp
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. AbbVie Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Bayer AG
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Macrolide Antibiotics Market Other Major And Innovative Companies

31.1. Sanofi S.A
31.2. Bristol-Myers Squibb Company
31.3. Abbott Laboratories
31.4. Novartis AG
31.5. GlaxoSmithKline plc.
31.6. Eli Lily and Company
31.7. Amgen Inc.
31.8. Teva Pharmaceutical Industries Limited
31.9. Mylan N.V.
31.10. Daiichi Sankyo
31.11. Sun Pharmaceutical Industries Limited
31.12. Cipla Limited
31.13. Lupin Limited
31.14. Zydus Lifesciences Limited
31.15. Alkem Laboratories Ltd.

32. Global Macrolide Antibiotics Market Competitive Benchmarking

33. Global Macrolide Antibiotics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Macrolide Antibiotics Market

35. Macrolide Antibiotics Market Future Outlook and Potential Analysis

35.1 Macrolide Antibiotics Market In 2028 - Countries Offering Most New Opportunities
35.2 Macrolide Antibiotics Market In 2028 - Segments Offering Most New Opportunities
35.3 Macrolide Antibiotics Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer